![Why Did Tesla Stock [TSLA] Rise Again?](https://cleantechnica.com/wp-content/uploads/2025/04/Screenshot-2025-04-10-at-3.31.36 AM.png)
Eli Lilly pens Creyon Bio AI oligonucleotide pact with $1B in biobucks on the table
Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio.
Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio.
